RankAlpha logo
Back to Rankings

SCYX

SCYNEXISD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
SCYX vs peer average
52/100
SCYX vs. peer average (D vs. D)
Grade spread
B 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

GRCE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $39.55M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGRCEGrace Therapeutics
SCYX
SCYNEXIS
GRCE
Grace Therapeutics
Grade
D
B
Momentum
21
70
Value
58
41
Sentiment
-
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs GRCE

SCYX / GRCE
Grade Position
In line
SCYX vs. peer average (D vs. D)
52/100
Momentum
21
GRCE
Value
58
SCYX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SCYX
1
GRCE
Grace Therapeutics Inc Common
B
80/100
-2
2
RNXT
RenovoRx Inc Common
D
40/100
Even
3
APLM
Apollomics Inc Class A Common
B
80/100
-2
4
CRVO
CervoMed Inc Common
F
20/100
+1
5
GNTA
Genenta Science SpA ADR
F
20/100
+1
GRCE is the first peer returned for this comparison set.